CXCR1/2 and their ligands are both expressed by lung cancer cells, and receptor inhibition with an antagonist decreased migration and enhanced apoptosis in vitro and suppressed tumor growth, metastasis, and angiogenesis in a mouse xenograft model 101. This evidence concerns the gene CXCR1 and lung cancer.